Share

    


Home / Search Results

Search Results

Search Publications

Search Again?

Filter By Content Type

Filter By Topic

tools 96 OI | Vol. 39, No. 3, 2024 | accc-cancer.org granted fast-track designation to CTX-009 in combination with paclitaxel for the treatment of patients with metastatic or locally advanced biliary tract cancer that has been previously treated. ● GSK, PLC (gsk.com) announced the FDA accepted the supplemental biologics license application (BLA) for Jemperli® (dostarlimab) in combination …
A spotlight on The Commonwealth Healthcare Corporation, Oncology Center, located in the Commonwealth of the Northern Mariana Islands.
July 20, 2024
Embark on a journey of professional growth and knowledge exchange with the Minnesota Society of Clinical Oncology (MSCO) at its annual Professional Development Workshop, held in conjunction with the Mayo Clinic College of Medicine. This workshop offers practical insights and networking for early-career and seasoned healthcare professionals. Fellows and residents will receive a $225 participation …
July 20, 2024
Join us in Dallas for the Best of ASCO Dallas July 20th - 21st! Gaylord Texan Resort & Convention Center 1501 Gaylord Trail Grapevine, TX 76051 Best of ASCO®, an Official Annual Meeting Review of the American Society of Clinical Oncology® (ASCO®), is a two-day program designed to provide the latest science and education from the world’s premier oncology event, the ASCO® Annual Meeting. The abstracts …
July 20, 2024
Saturday, July 20 | 7:00 AM - 5:00 PM Sunday, July 21 | 7:00 AM - 2:15 PM Best of ASCO®, an Official Annual Meeting Review of the American Society of Clinical Oncology® (ASCO®), is a two-day program designed to provide the latest science and education from the world’s premier oncology event, the ASCO® Annual Meeting. The abstracts selected for presentation and discussion reflect the foremost research …
July 19, 2024
Empowering Oncology Professionals by Enhancing Cancer Care Through Innovation and Knowledge Deep Dives into Immunotherapy: Explore the latest strategies to improve outcomes, tackle resistance, and personalize treatment plans. Precision Medicine in Practice: Learn how next-generation sequencing (DNA and RNA) is revolutionizing cancer care, making personalized treatment a reality for patients across …
Gain insights on reshaping multidisciplinary cancer care team workflows to enable laboratory professionals to improve biomarker testing efficiency.
July 18, 2024
Attend the 14th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2024) annual conference, which will be held on July 18-20, 2024, in Honolulu, Hawaii. This meeting will be hosted by the Physician Education Resource (PER) in-person for the first time ever in the United States. The APPLE Association is a professional organization dedicated to the research, prevention, and treatment of primary …
ROCKVILLE, MD - After a nationwide search, the Board of Trustees of the Association of Cancer Care Centers (ACCC) announced today the selection of Meagan O. O’Neill, MS, to be the new Executive Director. In the 50-year history of ACCC, O’Neill will serve as only the third Executive Director and the first woman in the role. ACCC, the leading education and advocacy organization for multidisciplinary …
ACCC recognizes July as Sarcoma and Bone Cancer Awareness Month.
This accelerated delivery platform improves clinic workflow and speeds up breast cancer diagnosis and treatment planning.
1 Copyright© 2024 ADVI Health. All Rights Reserved.Copyright© 2024 ADVI Health. All Rights Reserved. TxSCO Update July 11, 2024 ADVI & HillCo 2 Copyright© 2024 ADVI Health. All Rights Reserved. Agenda Federal • 2024 Election • New Medicare Part B Drug Reimbursement Proposal • AMA Supports Legislation to Replace MIPS with DPPS • Supreme Court Rulings: Healthcare Implications …
This content is being shared with permission from MJH Life Sciences. All content of Targeted Oncology is independently created and owned by MJH Life Sciences. TACOS ONCOLOGY DRUG NEWSLETTER J U LY 2 0 2 4 FDA APPROVALS Lisocabtagene maraleucel (liso-cel; Breyanzi) The FDA has approved the chimeric antigen receptor (CAR) T-cell therapy lisocabtagene maraleucel (liso-cel; Breyanzi) for …
This content is being shared with permission from MJH Life Sciences. All content of Targeted Oncology is independently created and owned by MJH Life Sciences. TxSCO ONCOLOGY DRUG NEWSLETTER J U LY 2 0 2 4 FDA APPROVALS Lisocabtagene maraleucel (liso-cel; Breyanzi) The FDA has approved the chimeric antigen receptor (CAR) T-cell therapy lisocabtagene maraleucel (liso-cel; Breyanzi) for …
OI | Vol. 39, No 3, 2024 | accc-cancer.org 2024 Trending Now in Cancer Care: Part 1 Collaborative Care Models Community Engagement Comprehensive Cancer Care Services Oncology Workforce Challenges ✚ 24 25 Facilitators • Amy Corrao, MSN, NP-C, scientific director, US Medical Affairs–Cellular Therapy at Bristol Myers Squibb • Kelly …
July 13, 2024
Total Health in partnership with the University of Hawaii are excited to bring you the 2024 ASCO Direct™ Hawaii conference. Sponsored by the Hawaii Society of Clinical Oncology (HSCO), this free, two-day, in-person conference is an officially licensed ASCO Direct meeting. We will showcase the ‘Best of’ abstracts selected from the 2024 ASCO Annual Meeting, allowing attendees learn and incorporate the …
July 11, 2024
You’re invited to participate in the Targeted Oncology™ Community Case Forum™ on Thursday, July 11 at The Ritz-Carlton, Denver in Denver, Colorado. HRA® offers compensation of $750 to medical oncologists/hematologists for their consultative insights. With prior approval from our registration team, a small number of fellows and advanced practice providers may be eligible to attend. After arriving, …
A recent legislation granting senior citizens covered by Medicare access to advanced cancer screenings passes a key milestone in the US House of Representatives.